$Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity$

Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity

PURPOSE: To report our experience with the use of the botulinum toxin-A (BoNT/A) formulations Botox® and Prosigne® in the treatment of neurogenic detrusor overactivity (NDO). MATERIALS AND METHODS: At a single institution, 45 consecutive patients with refractory urinary incontinence due to NDO recei...

Full description

Bibliographic Details
Main Authors:	Cristiano M. Gomes, Jose E. de Castro Filho, Ronald F. Rejowski, Flavio E. Trigo-Rocha, Homero Bruschini, Tarcisio E. P. de Barros Filho, Miguel Srougi
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2010-02-01
Series:	International Brazilian Journal of Urology
Subjects:	botulinum toxins urinary bladder neurogenic bladder urinary incontinence urodynamics
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382010000100011

Similar Items

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
by: Yuan-Hong Jiang, et al.
Published: (2020-12-01)

Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury
by: Sheng-Fu Chen, et al.
Published: (2022-01-01)

Botulinum toxin A for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients
by: S. Deffontaines-Rufin, et al.
Published: (2011-10-01)

A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure
by: Kwang Jin Ko, et al.
Published: (2019-03-01)

Long-term response of different Botulinum toxins in refractory neurogenic detrusor overactivity due to spinal cord injury
by: Giuseppe Lombardi, et al.

Phasic or terminal detrusor overactivity in women: age, urodynamic findings and sphincter behavior relationships
by: Françoise A. Valentini, et al.
Published: (2011-12-01)

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020-09-01)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
by: Shang-Jun Wu, et al.
Published: (2019-01-01)

Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment
by: Agnieszka A. Licow-Kamińska, et al.
Published: (2023-12-01)

Increased detrusor collagen is associated with detrusor overactivity and decreased bladder compliance in men with benign prostatic obstruction
by: Carlos H.S. Bellucci, et al.
Published: (2017-06-01)

Sphingosine Kinase 1 urothelial expression is increased in patients with neurogenic detrusor overactivity
by: Quentin Ballouhey, et al.
Published: (2015-12-01)

Idiopathic and neurogenic detrusor overactivity: do the different patterns have urodynamic characteristics related to gender or neurological condition?
by: Francoise A. Valentini, et al.
Published: (2013-09-01)

Does botulinum therapy affect the urine microbiome of patients with neurogenic bladder? Metagenomic sequencing results
by: E. S. Philippova, et al.
Published: (2020-10-01)

Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity
by: Ronaldo A. Alvares, et al.
Published: (2010-12-01)

Improved model for the establishment and evaluation of detrusor overactivity in female Wistar rats
by: Nian-zhao Zhang, et al.
Published: (2014-06-01)

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
by: Maryam Emami, et al.

Early treatment improves urodynamic prognosis in neurogenic voiding dysfunction: 20 years of experience
by: Lucia M. Costa Monteiro, et al.
Published: (2017-07-01)

Early treatment improves urodynamic prognosis in neurogenic voiding dysfunction: 20 years of experience,
by: Lucia M. Costa Monteiro, et al.

Urinary Oxidative Stress Biomarkers in the Diagnosis of Detrusor Overactivity in Female Patients with Stress Urinary Incontinence
by: Wei-Hsin Chen, et al.
Published: (2023-01-01)

Urodynamic characteristics of lower urinary tract of patients with idiopathic overactive bladder
by: Yuriy M Dekhtiar, et al.
Published: (2019-01-01)

Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease
by: Gregory Vurture, et al.
Published: (2019-09-01)

Dissimilar Effects of Tolterodine on Detrusor Overactivity in Awake Rats with Chemical Cystitis and Partial Bladder Outlet Obstruction
by: Long-Hu Jin, et al.
Published: (2011-09-01)

Typical Value Ranges and Typical Signal Patterns in the Initial Cough in Patients With Neurogenic Bladder: Quality Control in Urodynamic Studies
by: Tianji Lu, et al.
Published: (2016-09-01)

Efficacy and Safety of Low-Dose Intravesical OnabotulinumtoxinA Injections in Female Patients With Detrusor Overactivity With Detrusor Underactivity
by: Hyun Seok Na, et al.
Published: (2024-03-01)

The Current Positioning of Augmentation Enterocystoplasty in the Treatment for Neurogenic Bladder
by: Seong Jin Jeong, et al.
Published: (2020-09-01)

Detrusor after-contraction: a new insight
by: Françoise A. Valentini, et al.
Published: (2015-06-01)

Real-Time Documentation of the Effect of Onabotulinumtoxin A Detrusor Injection in OAB Patients—Preliminary Results
by: Heinrich Schulte-Baukloh, et al.
Published: (2022-12-01)

Challenges and practical considerations in delivering botulinum neurotoxin to adults with congenital neurogenic lower urinary tract dysfunction with history of genitourinary reconstruction
by: Johnny S. Su, et al.
Published: (2024-09-01)

Lower urinary tract dysfunction in the central nervous system neurogenic bladder and the real-life treatment outcome of botulinum toxin A
by: Hann-Chorng Kuo
Published: (2024-05-01)

Botulinum Toxin Injection for Medically Refractory Neurogenic Bladder in Children: A Systematic Review
by: Shu-Yu Wu, et al.
Published: (2021-06-01)

Augmentation cystoplasty in neurogenic bladder
by: Bülent Çetinel, et al.
Published: (2016-09-01)

Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions
by: Yuan-Hong Jiang, et al.
Published: (2024-03-01)

Overactive bladder in women with stress urinary incontinence
by: A. I. Neymark, et al.
Published: (2014-11-01)

Overactive bladder in women with stress urinary incontinence
by: A. I. Neymark, et al.
Published: (2014-11-01)

Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence
by: Margarida Manso, et al.
Published: (2024-07-01)

Effectiveness of onabotulinumtoxin A for refractory overactive bladder with cough‐associated detrusor overactivity
by: Chie Nakai, et al.
Published: (2024-05-01)

The Effect of Rehabilitation Nursing Interventions on the Quality of Life in Women With Neurogenic Bladder Dysfunction
by: Asieh Soghrati, et al.
Published: (2022-12-01)

Predictors of Nerve Stimulator Success in Patients With Overactive Bladder
by: Kristian D. Stensland, et al.
Published: (2018-09-01)